| Source: |
| Type: |
| Drug dosage vs efficacy, and actual dosage number of research papers. |
| 6430- | FEO, | Foeniculum vulgare: A comprehensive review of its traditional use, phytochemistry, pharmacology, and safety |
| - | Review, | Nor, | NA |
| 6428- | FEO, | Eug, | Triggering of apoptosis and cell cycle arrest by fennel and clove oils in Caco-2 cells: the role of combination |
| - | in-vitro, | Colon, | Caco-2 |
| 6890- | Fer, | Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues |
| - | vitro+vivo, | Var, | NA |
| 6917- | FIS, | Dietary flavonoid fisetin regulates aluminium chloride-induced neuronal apoptosis in cortex and hippocampus of mice brain |
| - | in-vivo, | AD, | NA | - | in-vivo, | Park, | NA |
| 6920- | FIS, | A phase II randomized placebo-controlled study of fisetin to improve physical function in breast cancer survivors: the TROFFi study rationale and trial design |
| - | Trial, | BC, | NA |
| 6921- | FIS, | The Effects of Fisetin on Reducing Biological Aging: A Pilot Study |
| - | Human, | Nor, | NA |
| 6901- | FIS, | Fisetin induces G2/M phase arrest and caspase-mediated cleavage of p21Cip1 and p27Kip1 leading to apoptosis and tumor growth inhibition in HNSCC |
| - | in-vivo, | HNSCC, | CAL33 |
| 6899- | FIS, | Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells |
| - | in-vitro, | Pca, | LNCaP | - | in-vitro, | Pca, | PC3 | - | in-vitro, | Pca, | 22Rv1 |
| 2854- | FIS, | New Perspectives for Fisetin |
| - | Review, | Var, | NA | - | Review, | Stroke, | NA |
| 2827- | FIS, | The Potential Role of Fisetin, a Flavonoid in Cancer Prevention and Treatment |
| - | Review, | Var, | NA |
| 2828- | FIS, | Fisetin, a Potent Anticancer Flavonol Exhibiting Cytotoxic Activity against Neoplastic Malignant Cells and Cancerous Conditions: A Scoping, Comprehensive Review |
| - | Review, | Var, | NA |
| 6930- | FLS, | 40 Hz light flickering facilitates the glymphatic flow via adenosine signaling in mice |
| - | in-vivo, | Nor, | NA |
| 6933- | FLS, | AudGS, | Gamma sensory stimulation in mild Alzheimer's dementia: An open-label extension study |
| - | Trial, | AD, | NA |
| 6982- | Form, | Formononetin: A Review of Its Anticancer Potentials and Mechanisms |
| - | Review, | Var, | NA |
| 6987- | Form, | Formononetin exhibits anticancer activity in gastric carcinoma cell and regulating miR-542-5p |
| - | vitro+vivo, | GC, | SGC-7901 | - | in-vitro, | BC, | MGC803 |
| 6964- | Form, | Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo |
| - | vitro+vivo, | BC, | MCF7 |
| 6967- | Form, | BTZ, | Formononetin Regulates Multiple Oncogenic Signaling Cascades and Enhances Sensitivity to Bortezomib in a Multiple Myeloma Mouse Model |
| - | in-vivo, | Melanoma, | U266 | - | in-vivo, | Melanoma, | RPMI-8226 |
| 6969- | Form, | Formononetin inhibits tumor growth by suppression of EGFR-Akt-Mcl-1 axis in non-small cell lung cancer |
| - | vitro+vivo, | NSCLC, | HCC827 | - | in-vitro, | NSCLC, | A549 | - | in-vitro, | Lung, | H1299 |
| 6971- | Form, | In vitro and in vivo anti-cancer activity of formononetin on human cervical cancer cell line HeLa |
| - | vitro+vivo, | Cerv, | HeLa |
| 6972- | Form, | PacT, | Formononetin ameliorates the drug resistance of Taxol resistant triple negative breast cancer by inhibiting autophagy |
| - | in-vivo, | BC, | MDA-MB-231 |
| 8303- | FS, | The relative bioavailability of enterolignans in humans is enhanced by milling and crushing of flaxseed |
| - | Trial, | Nor, | NA |
| 8307- | FS, | lign, | Efficacy and safety of a flaxseed hull extract in the symptomatic management of benign prostatic hyperplasia: a parallel, randomized, double-blind, placebo-controlled, pilot study |
| - | Trial, | BPH, | NA |
| 8300- | FS, | Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery |
| - | Trial, | Pca, | NA |
| 8588- | FS, | Tam, | Dietary flaxseed and tamoxifen affect the inflammatory microenvironment in vivo in normal human breast tissue of postmenopausal women |
| - | in-vivo, | BC, | NA |
| 8581- | FS, | Dietary Modulation of the Human Gut Microbiota and Metabolome with Flaxseed Preparations |
| - | in-vivo, | Nor, | NA |
| 8578- | FS, | High alpha-linolenic acid flaxseed (Linum usitatissimum): some nutritional properties in humans |
| - | Human, | Nor, | NA |
| 8585- | FS, | Dietary flaxseed: Cardiometabolic benefits and its role in promoting healthy aging |
| - | Review, | Nor, | NA |
| 8587- | FS, | Rad, | Phase II Trial of Flaxseed to Prevent Acute Complications After Chemoradiation for Lung Cancer |
| - | Trial, | Lung, | NA |
| 8593- | FS, | Flaxseed consumption reduces blood pressure in patients with hypertension by altering circulating oxylipins via an α-linolenic acid-induced inhibition of soluble epoxide hydrolase |
| - | vitro+vivo, | Nor, | NA |
| 8598- | FSO, | Tras, | Flaxseed oil-trastuzumab interaction in breast cancer |
| - | in-vivo, | BC, | NA |
| 8600- | FSO, | doxoR, | Combining doxorubicin with a phenolic extract from flaxseed oil: Evaluation of the effect on two breast cancer cell lines |
| - | in-vitro, | BC, | MCF7 |
| 8597- | FSO, | Chemopreventive effects of dietary flaxseed oil on colon tumor development |
| - | in-vivo, | CRC, | NA |
| - | Trial, | Diabetic, | NA |
| 8603- | FSO, | Flaxseed oil supplementation decreases C-reactive protein levels in chronic hemodialysis patients |
| - | Trial, | Nor, | NA |
| 8602- | FSO, | Supplementation with Flaxseed Oil Rich in Alpha-Linolenic Acid Improves Verbal Fluency in Healthy Older Adults |
| - | Trial, | AD, | NA |
| 7011- | Fuc, | ATO, | VitA,RetA, | Fucoidan enhances the therapeutic potential of arsenic trioxide and all-trans retinoic acid in acute promyelocytic leukemia, in vitro and in vivo |
| - | vitro+vivo, | APL, | APL NB4 |
| 7012- | Fuc, | Fucoidan: A promising natural therapeutic agent for protecting human kidney health |
| - | Review, | EC, | NA |
| 7014- | Fuc, | 5-FU, | Low-Molecular-Weight Fucoidan as Complementary Therapy of Fluoropyrimidine-Based Chemotherapy in Colorectal Cancer |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | Colon, | Caco-2 |
| 7016- | Fuc, | Therapies from Fucoidan: New Developments |
| - | Review, | Var, | NA |
| 7018- | Fuc, | Absorption Study of Mozuku Fucoidan in Japanese Volunteers |
| - | Trial, | Nor, | NA |
| 7025- | Fuc, | Pilot clinical study to evaluate the anticoagulant activity of fucoidan |
| - | Human, | Nor, | NA |
| 7021- | Fuc, | Fucoidan Prevents the Progression of Osteoarthritis in Rats |
| - | in-vivo, | Arthritis, | NA |
| 7007- | Fuc, | The Therapeutic Potential of the Anticancer Activity of Fucoidan: Current Advances and Hurdles |
| - | Review, | Var, | NA |
| 4016- | FulvicA, | Shilajit: A Natural Phytocomplex with Potential Procognitive Activity |
| - | Review, | AD, | NA |
| 4026- | FulvicA, | Shilajitin Cancer Treatment: Probable Mode of Action |
| - | Review, | Var, | NA |
| 4028- | FulvicA, | Mineral pitch induces apoptosis and inhibits proliferation via modulating reactive oxygen species in hepatic cancer cells |
| - | in-vitro, | Liver, | HUH7 |
| - | in-vitro, | Oral, | NA |
| 1624- | GA, | Anticancer Effect of Pomegranate Peel Polyphenols against Cervical Cancer |
| - | in-vitro, | Cerv, | NA |
| 7044- | GA, | QC, | Inhibitory effects of gallic acid and quercetin on UDP-glucose dehydrogenase activity |
| - | in-vitro, | BC, | MCF7 |
| 7032- | GA, | Cisplatin, | Gallic acid: a polyphenolic compound potentiates the therapeutic efficacy of cisplatin in human breast cancer cells |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | Nor, | MCF10 |
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1114 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid